GlaxoSmithKline's ( GSK ) shares climbed 2.2% in pre-market trading after a majority of the U.S. Food and Drug Administration's panel voted to keep its controversial type 2 diabetes drug Avandia on the U.S. market, albeit with new restrictions. The diabetes drug already carries a black box label warning on elevated cardiac risk. The vote is not a decision. The regulatory authority still has to make... Continue reading GlaxoSmithKline Shares Up After Avandia Ruling GlaxoSmithKline Shares Up After Avandia Ruling originally appeared on DailyFinance on Thu, 15 Jul 2010 08:12:00. Filed Under: Company News , Investing , Health Care , GlaxoSmithKline , Stocks in the News Permalink | Tweet this! | Comments